Exclusive

Publication

Byline

Inspirata offers Free Remote Pathology Solution to tackle COVID-19

Singapore, April 10 -- Cancer informatics and digital pathology solution provider Inspirata announced earlier this week its free remote pathology initiative, available to healthcare institutions looki... Read More


Australia to use intravenous zinc in COVID-19 fight

A world, April 10 -- first trial will see researchers from Australia's Austin Health and the University of Melbourne, use intravenous zinc to fight the symptoms of coronavirus (COVID-19). The trial w... Read More


Genetron Health develops detection kit for COVID-19

Singapore, April 10 -- Genetron Holdings Limited (Genetron Health), a China-based precision oncology company that covers full-cycle cancer care, announces that its independently developed Detection Ki... Read More


West names Stewart Campbell VP& GM for APAC Region

Singapore, April 10 -- West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, recently named Stewart Campbell as the Vice President & General M... Read More


Sesderma Labs produces Lactyferrin to counter the COVID-19 strain

Singapore, April 10 -- Sesderma, a Spanish company specializes in Nanotechnology, has managed to produce an effective drug named Lactyferrin (LF) to counter the COVID-19 strain. Lactyferrin (LF) is kn... Read More


Australia offers financial aid to early phase clinical trials in APAC

Singapore, April 10 -- Leading Australian CRO Avance Clinical on 3 April 2020 detailed the top reasons it's APAC biotechs selected Australia for their early phase clinical trials, based on client onbo... Read More


Takeda and CSL Behring to Develop Potential COVID-19 Hyperimmune Therapy

Singapore, April 10 -- Takeda and CSL Behring, a provider of plasma-derived and recombinant therapies based in King of Prussia, PA, on 6 April 2020 announced a partnership to develop a potential plasm... Read More


Taiwan's Academia Sinica identifies potential COVID-19 inhibitors

Singapore, April 10 -- Taiwan's Academia Sinica in Taipei, Taiwan announced on 10 April 2020 that it has screened out protease inhibitors of the COVID-19 coronavirus, which could eventually lead to th... Read More


Chugai starts Ph III trial of Actemra for COVID-19 pneumonia

Singapore, April 9 -- Japan based Chugai Pharmaceutical Co., Ltd. has announced that it is working to start a Phase III clinical trial in Japan with the humanized anti-human IL-6 receptor monoclonal a... Read More


Bio-Rad launches serology assay to detect COVID-19 Abs

Bio, April 9 -- Rad Laboratories, Inc., a global leader of life science research and clinical diagnostic products, today announced that the company is launching a blood-based immunoassay kit to identi... Read More